# Multiple Dose Study In Cancer Patients: Safety and Tolerability of BMS-754807 in Advanced or Metastatic Solid Tumors

> **NCT00569036** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 63 (actual)

## Conditions studied

- Neoplasms
- Solid Tumors
- Metastases

## Interventions

- **DRUG:** BMS-754807

## Key facts

- **NCT ID:** NCT00569036
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2013-04
- **Final completion:** 2013-04
- **Target enrollment:** 63 (ACTUAL)
- **Last updated:** 2013-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00569036

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00569036, "Multiple Dose Study In Cancer Patients: Safety and Tolerability of BMS-754807 in Advanced or Metastatic Solid Tumors". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00569036. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*